secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2022-10-28T23:59:59+00:00
Accession:  0001493152-22-029837
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo shareholders elect three Class II directors, ratify auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- Directors elected: Nat Calloway (15,985,642 for, 7,456 withheld), Areta Kupchyk (15,982,304 for, 10,794 withheld), Kenneth Lin (15,982,304 for, 10,794 withheld).
- Ratification of EisnerAmper LLP as independent auditor for FY2023 approved: 15,992,762 for, 335 against, 1 abstention.
- No broker non-votes on director elections; broker discretionary voting allowed on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315222029837/0001493152-22-029837-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315222029837/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-029837

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer